University of Louisville’s Research Team Discovers Molecule That Protects Against Development of Cancer Cells

The University of Louisville’s publication UL News recently reported a finding by its research team regarding an immune checkpoint molecule.  The molecule had been developed for cancer immunotherapy but when…

Continue Reading University of Louisville’s Research Team Discovers Molecule That Protects Against Development of Cancer Cells
International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy
Source: Pixabay

International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy

Hypoparathyroidism Hypoparathyroidism (HP) is caused by low levels of the parathyroid hormone (PTH). Most people develop this disease after thyroid surgery as a result of accidental damage/removal of the parathyroid…

Continue Reading International Phase 2 Clinical Trial Initiated for New Potential Hypoparathyroidism Therapy

Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women

According to a study published in the Orphanet Journal of Rare Diseases, a study that was intended to identify a new approach to monitoring the progression of x-linked adrenoleukodystrophy in women…

Continue Reading Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women

Sexual Abuse in Medical Research: How Can Justice be Served?

Content Warning: The following article discusses sexual abuse. According to a story from Buzzfeed News, many former patients of an esteemed medical researcher named Reginald Archibald, who was affiliated with…

Continue Reading Sexual Abuse in Medical Research: How Can Justice be Served?

Oregon Health & Science University to Participate in Study to Predict Treatment Response for Rare Cancer

According to a story from IT Business Net, the medical company KIYATEC, Inc., has recently announced that that the Knight Cancer Institute at Oregon Health & Science University has joined…

Continue Reading Oregon Health & Science University to Participate in Study to Predict Treatment Response for Rare Cancer

Can Amyotrophic Lateral Sclerosis Patients Speak Again With New Technology?

The Importance of Speech The ability to speak gives individuals not only the opportunity to communicate with one another, it provides an outlet for expression, creativity, and connectedness. Unfortunately, that…

Continue Reading Can Amyotrophic Lateral Sclerosis Patients Speak Again With New Technology?
The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma
johnhain / Pixabay

The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma

According to a story from pm360online.com, The National Brain Tumor Society (NBTS) recently awarded $750,000 to the Global Coalition for Adaptive Research. This cash is slated to go towards the…

Continue Reading The National Brain Tumor Society Awards $750,000 Towards Adaptive Clinical Trial for Glioblastoma
Study Confirms Some Narcolepsy Diagnoses Can be Linked to the Flu
https://pixabay.com/en/virus-microscope-infection-illness-1812092/

Study Confirms Some Narcolepsy Diagnoses Can be Linked to the Flu

Emmanuel Mignot, who is the director of the Stanford Center for Sleep Sciences and Medicine has long believed that some onsets of Narcolepsy could be caused by a confused autoimmune response in…

Continue Reading Study Confirms Some Narcolepsy Diagnoses Can be Linked to the Flu

Orphan Drug Designation Granted to Potential New Hypereosinophilic Syndrome Treatment

Hypereosinophilic syndrome Hypereosinophilic syndrome (HES) refers to a group of rare conditions characterized by high levels of eosinophils which result in organ damage. These eosinophils often affect the lungs, heart, skin,…

Continue Reading Orphan Drug Designation Granted to Potential New Hypereosinophilic Syndrome Treatment

BridgeBio Receives Almost 300 Million for Continued Rare Disease Research

About BridgeBio Pharma BridgeBio Pharmaceuticals was created in 2015 by veterans from the fields of academia and biotechnology. The company focuses on the development of new therapeutic treatments for genetic…

Continue Reading BridgeBio Receives Almost 300 Million for Continued Rare Disease Research
Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
sabinurce / Pixabay

Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia

According to a story from Market Screener, the biopharmaceutical company Orchard Therapeutics recently announced that the results of a recent clinical trial testing the company' investigational product OTL-300 were encouraging.…

Continue Reading Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
Parliamentary Debate Highlights Continued Controversy and Misinformation Surrounding CFS/ME
marusya21111999 / Pixabay

Parliamentary Debate Highlights Continued Controversy and Misinformation Surrounding CFS/ME

According to a story from The ME Association, a recent debate that came to the floor of the UK parliament highlights the misinformation and deficits in care surrounding children with…

Continue Reading Parliamentary Debate Highlights Continued Controversy and Misinformation Surrounding CFS/ME